GIST

Population-Based Study of Adolescent and Young Adult GIST Patients

Jason Sicklick, M.D Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, M.D., indicate that small [...]

By |2018-10-30T09:23:26-04:00January 25th, 2017|News, Research|

Help MaKayla Realize Her Dream: Donate to double patient survival

MaKayla Evens help kick off our holiday campaign. MaKayla Evans was diagnosed with Wild Type GIST in 2011, when she was 14 years old. She wanted to speak knowledgeably with her doctors [...]

By |2020-01-31T11:01:40-05:00November 30th, 2016|Fundraising, Member Stories, News, Newsletter|

LOXO-101 receives breakthrough therapy designation from FDA for solid tumors with NTRK gene fusions

Loxo Oncology  announced in a press release that the FDA has granted breakthrough therapy designation to LOXO-101 for the treatment of unresectable or metastatic solid tumors with neurotrophic tyrosine receptor kinase gene fusions. This [...]

By |2020-02-21T14:56:38-05:00July 21st, 2016|News, Research|
Go to Top